Key terms at a glance

• $100,000 challenge fee: $619 (1-phase “Single Helix”), $549 (2-phase “Double Helix”), $549 (10-day Rapid), $979 (instant funding), per DNA Funded’s published pricing as compiled by TheTrustedProp (2026).
• Account sizes: $5,000 to $200,000.
• Profit targets: 10% (1-phase); 10% then 5% (2-phase); 5% within 10 calendar days (Rapid); none on instant funding.
• Drawdown: static on evaluations — 4% daily / 6% max (1-phase), 5% daily / 8% max (2-phase), 3% daily / 5% max (Rapid); instant funding runs a 4% trailing max with no daily limit.
• Profit split: 80%, upgradeable to 90% via paid add-on.
• Payout cycle: every 14 days (7 with add-on), minimum 5 trading days per cycle, minimum withdrawal $100; crypto (1% fee) or bank transfer ($50 flat).
• Payout caps: first three payouts capped at 5% of starting balance; 30% daily-profit distribution limit on accounts opened on or after February 3, 2026 (40% on legacy accounts).
• Platform: TradeLocker only.

What DNA Funded is

DNA Funded launched in 2024 as the proprietary-trading arm of the DNA Markets brand, the Australian brokerage regulated by the Australian Securities and Investments Commission (ASIC) — the broker-backed structure that peers like Blueberry Funded and FXIFY also market, per TradingFinder’s 2026 profile. The distinction matters and cuts both ways: pricing and execution route through a real regulated brokerage rather than a synthetic feed, but the challenge product itself sits in DNA Funded Ltd, a Saint Lucia company (registration 2025-00574) led by Chief Executive Officer Martin Doepke, outside any conduct regulator’s reach. The evaluation menu is one of the wider ones in FX prop: two conventional challenge tracks, a 10-day sprint, instant funding, and a $20,000 “24-hour challenge” lottery format with $25–$500 stakes and fixed payout multipliers — a product that looks considerably more like a wager than an evaluation, and which risk-conscious traders should treat accordingly.

The payout record

What can be verified: DNA Funded publishes payout terms of 14-day cycles processed in 1–4 business days, and reviewers across TheTrustedProp and Myfxbook’s prop directory report functioning withdrawals through crypto and bank transfer. What cannot be verified is more significant here than at larger rivals: the firm publishes no audited payout totals and no third-party payout tracker covers it at scale, so the record rests on a thin base of 72 Trustpilot reviews scoring 3.8 out of 5 — 55% positive, 39% one- and two-star. The negative cohort’s themes are specific: one trader reported chasing a $5,000 payout for two months; several describe the daily-profit consistency mechanics as poorly documented at purchase; one disputes an account action tied to abnormal silver (XAG/USD) pricing on a Monday open; and multiple reviewers say raising complaints got them removed from the firm’s Discord. No named trader with a public, checkable payout history has published a first-hand account we could quote — a gap in the record worth stating plainly.

The rules that void accounts and shrink payouts

DNA Funded’s evaluation drawdowns are static — genuinely simpler than the trailing mechanics that catch traders at FXIFY or Apex-style futures firms — but its payout mathematics are where accounts disappoint. Three mechanisms compound. First, the 5%-of-starting-balance cap on each of the first three payouts: a $100,000 account that runs up $15,000 in its first cycle can still withdraw only $5,000, leaving the rest exposed to the account’s drawdown rules for weeks. Second, the daily-profit distribution limit — 30% on accounts opened since February 3, 2026 — means no single trading day may contribute more than 30% of a requested payout; one big news-day win must be diluted by at least three other profitable days before it pays out in full. Third, the instant-funding tier swaps static for a 4% trailing maximum drawdown, the tightest number on the menu, on the account type marketed to the least patient buyers. None of these rules is hidden, but all three interact in ways the pricing page does not spell out — and the interaction, not any single rule, is the effective consistency regime.

How DNA Funded compares

Sources: each firm’s published terms as of August 1, 2026; see The Industry Spread’s Blueberry Funded review and FXIFY review for full rule breakdowns.

Regulatory posture

Be precise about what “broker-backed by an ASIC-regulated firm” buys. DNA Markets holds an Australian Financial Services Licence and answers to ASIC for its brokerage conduct — a regulator that has just posted a record A$830 million penalty year. DNA Funded Ltd, the entity that sells challenges and owes payouts, is a Saint Lucia registration from 2025 with no financial-services licence anywhere, which is the industry norm. Challenge accounts are simulated; funded capital is the firm’s capital; the fee is generally non-refundable; and a payout dispute is resolved under the firm’s own terms with no ombudsman behind it. The ASIC connection protects DNA Markets’ brokerage clients — it does not extend a compensation scheme or conduct rules to prop-challenge customers, a distinction the marketing does not volunteer.

FAQ

Is DNA Funded legit?

DNA Funded has operated since 2024, is attached to the ASIC-regulated broker DNA Markets, and functioning payouts are reported across reviewer platforms. It is not a scam on the observable record, but the record is thin — 72 Trustpilot reviews at 3.8, no audited payout data — and complaints centre on payout delays and under-documented consistency mechanics.

What does a DNA Funded $100K challenge cost?

As of 2026: $619 for the one-phase Single Helix, $549 for the two-phase Double Helix, $549 for the 10-day Rapid challenge, and $979 for instant funding. The 90% profit-split upgrade and 7-day payout cycle are paid add-ons on top of these fees.

What is DNA Funded’s consistency rule?

Two mechanisms: the first three payouts are each capped at 5% of starting balance, and on accounts opened on or after February 3, 2026 no single trading day may contribute more than 30% of a requested payout (40% on older accounts). Together they force profits to be spread across multiple days and payout cycles.

What platform does DNA Funded use?

TradeLocker only, connected to DNA Markets’ pricing. There is no MetaTrader option — a real limitation for traders running MT4/MT5 expert advisors, and a point where rivals like Blueberry Funded (MT4/MT5/TradeLocker) and FXIFY (MT4/MT5/DXtrade/TradingView) offer more choice.

Is DNA Funded regulated?

No. The challenge business is DNA Funded Ltd, a Saint Lucia company registered in 2025. The associated broker, DNA Markets, is ASIC-regulated for its brokerage activities, but that licence does not cover prop challenges, and no investor compensation scheme applies to challenge fees or simulated-account payouts.

This review is independent editorial analysis and is not financial, investment, or trading advice, and is not an endorsement or solicitation. The Industry Spread has no affiliate or referral relationship with the firms covered. Proprietary trading challenges carry a fee that is generally non-refundable, most participants do not reach a funded account, and funded capital is the firm’s capital, not the trader’s. Terms change frequently — always verify current rules directly with the firm before paying any fee.

Abdelaziz Fathi

Abdelaziz Fathi covers the intersection of forex/CFD brokerage, regulation, liquidity, fintech, and digital assets. With a B.A. in Finance and hands-on industry exposure, Aziz blends analytical rigor with clear storytelling to make complex market structure understandable for traders, brokers, and fintech professionals.